Editorial illustration. Not a research image, anatomical diagram or photograph of a tested product.
On October 2, 2023, the World Health Organization recommended R21/Matrix-M for malaria prevention in children. It was the second malaria vaccine recommend
Read More
Editorial illustration. Not a research image, anatomical diagram or photograph of a tested product.
On May 3, 2023, the FDA announced approval of Arexvy, the first respiratory syncytial virus vaccine approved in the United States. The original decision c
Read More
Editorial illustration. Not a research image, anatomical diagram or photograph of a tested product.
On July 2, 2024, the FDA announced approval of Kisunla, or donanemab-azbt, for Alzheimer’s disease. The decision was important, but the evidence is best u
Read More
Editorial illustration. Not a research image, anatomical diagram or photograph of a tested product.
On July 6, 2023, the FDA converted Leqembi, the brand name for lecanemab-irmb, from accelerated to traditional approval for Alzheimer’s disease after a co
Read More
Editorial illustration. Not a research image, anatomical diagram or photograph of a tested product.
On December 8, 2023, the U.S. Food and Drug Administration announced approval of Casgevy for a defined group of people with sickle cell disease. It was th
Read More